Try our Advanced Search for more refined results
Health - March, 2010
236 articles
- Pfizer Reveals $35M Payout To Docs, Hospitals In '09
- Allstate Owes Wyeth Defense For Ativan Suits: Judge
- Arthrex, DePuy Reach Accord On ACL Patent Suit
- Hospice Org. Beats Nurses' On-Call Wage Suit
- Pfizer Not Excited About Teva's Generic Viagra
- Bayer Fails To Scrap Aspirin Marketing MDL
- Alphapharm Drops Antitrust Claims In Treximet IP Suit
- Toshiba Strikes Deal In Innurvation Circuit Patent Row
- Cephalon Off-Label Class Action Won't Be Reopened
- DNA — Not Patentable Subject Matter ...
- Astra Told To Pay Dr. Reddy's Fees In Prilosec Suit
- Gene Patent Ruling Could Shake Up Biotech
- Bayer Keeps Some Expert Opinions Out Of Trasylol MDL
- High Court Puts Restrictions On Whistleblower Suits
- Sandoz Seeks To Appeal Ruling In Effexor Spat
- Techs Sue Carl Zeiss Over Exempt Reclassification
- E-Mail To Attys From Work Privileged: NJ High Court
- Class Approved In Wal-Mart Workers' Comp Spat
- Sidley Life Sciences Patent Pro Joins Quinn Emanuel
- Biosimilars Pathway: A Far Cry From Hatch-Waxman
- MDCO Sues Again For Extension Of Angiomax Patent
- Astellas Wins Look At OSI's Books Amid $3.5B Bid
- Antitrust Claims Survive In Cephalon Pay-To-Delay War
- $180M Lasik Plaintiff Gives TLC Plan The Stink Eye
- Sandoz Antitrust Claims Nixed In Bayer's Yaz IP Suits
- Merck Deal, With $3.5M In Fees, OK'd Over Objections
- 7th Circ. Sends Bayer HIV Claims To Taiwan
- Senate Again Lets Federal Insurance Plans Lapse
- Workers Drop Doffing Claim In Bristol-Myers Suit
- Fed. Circ. Refuses To Nix Bayer's Animal Drug IP Suit
- Bill Would Extend COBRA To Domestic Partners
- AGA To Pay $35M To End Medtronic Stent Patent Suit
- Fed. Circ. Revives Enzo, Applera DNA Patent Case
- Judge Allows Baxter AWP Qui Tam Suit To Proceed
- KV Pharmaceutical ERISA Class Action Tossed
- Purchasers' Antitrust Suits Over Generic Plavix Tossed
- Plaintiffs' Lawyers Seek MDL For Pain Pump Suits
- TLC Vision's 4th Amended Ch. 11 Plan A Go
- Jury Hands $142M Win To Kaiser In Neurontin Battle
- Bayer Eludes Suit Over Multivitamin Marketing
- Mylan Antitrust Suit Over Mirapex Patent Sent To Del.
- EU Seeks Recall Of Acino Blood Thinner Clopidogrel
- The Written Description Requirement: It's Still Here
- Cerberus Buys Health Care Group For $830M
- Reverse Payment Suit Over Generic K-Dur Tossed
- Fed. Circ. Upholds Illumina Win In DNA Patent Spat
- Genzyme Says FDA Inspectors Will Oversee Plant
- Stryker Can't Escape Punitive Damages In Pump Suit
- AstraZeneca OT Class Action Halted On Appeal
- Biogen Targets GSK's Cancer Drug Arzerra In IP Suit
- Stage-Setting For Circ Split: Generic Drug Preemption?
- Teva's $70M ARS Suit Against Deutsche Tossed
- Qui Tam Relator Barred From Suing Purdue: 4th Circ.
- Fed. Circ. Overturns $1.1M Pressure Products IP Win
- Gen-Probe Sues Becton Dickinson Again Over Test IP
- Medtronic Hit With Antitrust Suit Over Spine Treatments
- Axonyx Off Hook For Alzheimer's Drug Securities Suit
- AMRI, Sanofi Ask Judge To Block Generic Allegra
- Physician Payment Reporting Obligations: A Reality
- Walgreen To Cough Up $6M Over Wal-Born Claims
- Ariad Ruling Bolsters Written Description Requirement
- Alcon Lens Patent Suit Headed To Trial In One Piece
- Sanofi, Toshiba, Others Hit With False Marking Suits
- Jury Hands Covidien $4.8M In Surgical Device IP Case
- Patent Deemed Invalid In Edwards Heart Valve Suit
- State AGs Attack 'Unconstitutional' Health Care Bill
- Shire, Nostrum Strike Patent Deal Over Epilepsy Drug
- Obama Signs Health Care Bill As GOP Eyes Repeal
- Oracle Fights $75M Spheris Sale To MedQuist, CBay
- Medical Experts Allowed In Pfizer Securities Suit
- Securities America Sued Over $2B Med Cap Fraud
- FDA Suspends Use Of GSK's Rotavirus Vaccine
- Follow-On Biologics: Is Your Patent Portfolio Ready?
- Fed. Circ. Reaffirms Written Description Doctrine
- Medical Providers Can't Arbitrate PPO Fight: 5th Circ.
- Insurer Told To Cover Hospital For Nurse's Murders
- Biomet Off Hook For Elbow Fixator Claims
- FDA Investigates Boston Scientific Defibrillator Recall
- Health Care Bill Heads To Obama's Desk
- Cell Therapeutics Sued Over 'False' New Drug Filings
- State AGs Plan To Fight Health Care Reform Law
- Guidant ERISA Plaintiffs Seek OK For $7M Settlement
- Supreme Court Won't Hear Tenn. Fen-Phen Case
- NJ Jury Finds For AstraZeneca In 1st Seroquel Verdict
- Alcon Shareholder Drops Bid To Block Novartis Deal
- Duane Reade Denies Owing Kasowitz Benson $7M Fee
- Norvir And The Difficulties In Analyzing Bundling
- Nonprofit Hospital Fails Tax Exemption Test: Court
- Sanofi, Dabur Patent Dispute Over Eloxatin Survives
- Chantix MDL Plaintiffs Roll Out Master Complaint
- St. Jude Medical In Hot Water Over 'False' Financials
- Ex-Biovail Exec Can't Dodge SEC Fraud Suit
- Pristiq-Related ERISA Suit Against Wyeth Gets Booted
- Lilly Takes Aim At Synthon Over Adcirca ANDA
- Pay-For-Delay Ban Dropped From Health Care Bill
- Pfizer Drops Suit Against Lilly Over Viagra Patent
- Former King & Spalding Partner Forms IP Boutique
- Solvay Settles Estratest False Marketing Suit For $16M
- Medtronic ERISA Suit Over $510M IP Payouts Tossed
- Claims Pared In Dey, Sepracor IP Fight Over Brovana
- Kirkland Represents Teva In $5B Ratiopharm Deal
- Focusing On Food Labeling Enforcement
- 2nd Circ. Seeks Input On Time Bars In Ephedra Case
- Top DOJ Health Fraud Cop Heads To Arnold & Porter
- Purdue To Settle OxyContin Antitrust MDL: Atty
- Highmark Says Pa. Insurance Head Abused Authority
- Tentative Deal Struck In Gilead Securities Action
- Fredrikson & Byron Reps Medtronic In $3B Debt Offering
- MDCO Gets 2nd Shot At Angiomax Patent Extension
- Asahi Kasei Ends Suit Over $91M Arbitration Award
- Mylan, Takeda Bury Hatchet In Diabetes Drug Feud
- Astellas Attempts To Oust OSI Board In Takeover Bid
- Amacore Directors Dropped From $14M Merger Spat
- Cephalon Goes After Lupin In 6th Nuvigil Patent Suit
- I-Flow Pump Liability Suits Survive Summary Bid
- Alpharma To Pay $42.5M Over Morphine Marketing
- Schering, Neutrogena Ads Are Both Misleading: Judge
- Inventor Tafas Seeks Fees In Suit Over USPTO Rules
- FTC Warning Letters: A New Era Of Enforcement?
- Trilipix ANDA Spurs Abbott, Fournier To Sue Impax
- Teleflex Issues IV Recall Over Possible Contamination
- KV Pharma Dodges WARN Act Class Action
- Boston Scientific Recalls 2 Types Of Defibrillator
- FDA Discovers Slew Of Quality Issues At Amylin Plant
- Cephalon Patent Suit Over Amrix Survives Dismissal
- FDA Slaps Black Box Warning On Plavix
- Pfizer Asserts 2nd Lyrica Patent Against Mylan
- Kaiser Asks To Admit 'Snake Oil' Barb In Neurontin Trial
- Fresenius Infringes Sanofi's Eloxatin Patent: Judge
- Sanofi To Pay $15M To Settle Sex Bias Class Action
- Antitrust Enforcement Of Hospital Consolidations
- OSI Board Rejects Astellas $3.5B Bid
- Merial Pig Vaccine Patent Suit Sent To Conn.
- Jury Rejects Antitrust Claims In Houston Hospital Spat
- Fed. Claims Court Finds No Thimerosal-Autism Link
- Ranbaxy, Takeda Strike Licensing Deal Over Actos
- Shimadzu Resolves Caliper DNA Patent Suit
- CCS Medical's Ch. 11 Plan Approved
- IntelliPharmaCeutics, Elan Settle Focalin Patent Spat
- Antitrust Claims Cut From Philips, Masimo IP Spat
- Medivation Sees Shareholder Ire Over Alzheimer's Drug
- Inyx USA Wins Reorganization Plan Approval
- Roxane Agrees To Hold Off On Generic Asacol
- Teen's Suit Against Teva Over Acne Drug Survives
- BMS, Novartis Sue Teva Over HIV Drug Reyataz
- Abbott Ordered To Turn Over E-Mail To Depakote Probe
- Citizens United: A Congressional Opportunity
- Metabolite, LabCorp Royalties Spat Sent To 10th Circ.
- Abbott Labs To Buy Facet Biotech For $450M
- Teva Sues Mylan Over Seasonique ANDA
- GlaxoSmithKline Infringes Antibody Patent: Genentech
- Health Net Hit With FLSA Suit By Call Center Workers
- Siemens Flays Sobha Over Failed $65M Deal
- Wyeth, Biovail Deal Over Generic Effexor Wins OK
- 9th Circ. Revives Expert Testimony Against Howmedica
- Feds Probe Medtronic's Link To Mass. Clinic
- Sanofi Loses Injunction Bid In Generic Eloxatin Spat
- Wilson Sonsini Lures Back Cytokinetics GC
- $2B NY Medicare Fraud Suit Tossed
- Smith & Nephew Infringed Wound Treatment IP: Jury
- Allen & Overy Reps Novartis In $5B 3-Part Bond Issue
- Biovail Targets Paddock Over Aplenzin ANDA
- OHIC Wins $6.1M Prejudgment Interest From Reinsurer
- General Medicine Tries Again For $376M Judgment
- Calif. Appeals Court Backs MDA Preemption Clause
- Watson To License Takeda's Actos In Patent Deal
- GSK Tries To Axe Wellbutrin Consumer Antitrust Suit
- Supply Cos.' Antitrust Claims Against Hospitals Tossed
- GSK Tries To Halt Teva's Generic Combivir Launch
- Linklaters, Fried Frank Advise On Sanofi, Merck Deal
- Actavis Settles Mass. Medicaid Price Claims For $4M
- Watson's Opana ANDA Triggers Endo, Penwest Suit
- FDA Chief Walks Tightrope In 2011 Budget Talks
- National Union Says No To Forba Dental Scam Suit
- $1M Trimmed From $4.8M Award Over Remicade Ads
- Cost-Containment And The Need For Health Courts
- Sanofi-Aventis Units Look To Toss False Claims Suit
- Bid For TLC Vision Equity Committee Shot Down
- Graceway, 3M TRO Request In Nycomed Case Denied
- OxyContin Buyers Resolve Purdue Antitrust Claims
- Faced With Antitrust Suit, BCBS Michigan Nixes Deal
- Merck's Patent Tactics Violate Antitrust Law: Suit
- Health Insurers Told To Post Premium Justifications
- Supreme Court Narrows Scope Of Speedy Trial Act
- Celgene, Novartis Resolve ADHD Patent Suits
- 11th Circ. Upholds Dismissal Of Paxil Suicide Case
- Supreme Court To Tackle Vaccine Injury Preemption
- Atty Sanctions Sought In Merck-Schering Merger Suit
- AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit
- AstraZeneca Squashes Anasthetic Warning Suit
- Cooper Cos. Fails To Shake Securities Class Action
- Jury To Decide Secrets Spat Between Doctor, Mayo
- 'Intellact' Trademark Suit Survives Intel Dismissal Bid
- Australian Ruling Opens Door For 100s Of Vioxx Claims
- 9th Circ. Says No To Calif. Medicaid Cuts
- 40 Cases In Aredia, Zometa MDL Survive Dismissal Bid
- Bill Proposes Federal Veto For Health Premium Hikes
- Insurers Resolve Lifeline Coverage Dispute In 6th Circ.
- A Health Reform Workaround
- Attorneys Fear Return Of Outside Compliance Monitors
- GAO Issues Scathing Review Of FDA Probe Oversight
- Nestle, Others Targeted By FDA Over Misleading Labels
- Pfizer Patent Adjustment Fight Remanded To USPTO
- 8th Circ. Upholds Another Dismissal In Baycol MDL
- Transitions Resolves Claims Over Eyewear Deals
- Pfizer Spits Out Class Cert. In Listerine Ad Suit
- KV Unit Ethex To Pay $28M In Oversize Pill Case
- FDCA Precludes Wyeth Protonix Lanham Suit: Court
- Boehringer Seeks To Divide Claims In AWP Case
- AstraZeneca Escapes Liability In Pain Pump Suit
- Prilosec Food Poisoning Suit Gets The Boot
- Boston Scientific Cross-Appeals Stent Patent Ruling
- Federal Insurance Programs Extended After Delay
- Amgen ERISA Case Doesn't Hit Proper Targets: Judge
- Human Tissue MDL Plaintiffs Denied Class Cert.
- Utah Court Tosses AG's AWP Suit
- DC Circ. Boosts Teva In Row With FDA Over Merck Drugs
- Sanofi Loses Last-Ditch Bid To Upend Eloxatin Deal
- AstraZeneca Slaps Sun Pharma Over Nexium IV Generic
- The Latest Swipe At Insurers' Antitrust Exemption
- Jilted Health Co. Investors' Insurance Claim Rejected
- Ex-Execs Of WebMD Unit Convicted Of Conspiracy
- USHealth Dismissed From Cancer Insurance Suit
- Ortho, Braun Marked Drugs With Expired Patents: Suits
- Stryker Loses Bid To Toss Pain Pump Liability Suit
- Calif. County Sues GSK Over Alleged Avandia Risks
- Senate Delays Threaten Federal Insurance Programs
- Court OKs Ex-McKesson HBOC GC's Deal With SEC
- Enzo Wins Interference Ruling In Siemens Patent Spat
- Nelson Levine Lures Another Cozen O'Connor Atty
- AstraZeneca To Pay Merck $647M For Drug Stake
- Astellas Ups Ante In $3.5B Hostile Bid For OSI
- Wyeth, Apotex Vie For Quick Win In Effexor Patent Suit
- CVS Hits KV With $100M Claim Over Recalled Drugs
- Merck To Buy Biotech Co. Millipore For $7.2B
- Baxter To Pay Up To $330M To Buy ApaTech